CMS finalizes the 2026 Medicare OPPS and ASC payment rates with a 2.6% increase, including quality reporting penalties and maintained 340B payment adjustments.

Explore how the expansion of Medicare Advantage plans affects rural hospitals, reimbursement rates, patient access, and marketing practices impacting Medicare beneficiaries and healthcare providers in the U.S.

The CARE Act proposes a Medicare pilot program to reimburse EMS providers for on-scene care, aiming to reduce unnecessary ER visits and enhance EMS capacity.

Bipartisan Senate talks progress on ending the U.S. government shutdown with a plan to reopen and schedule an Obamacare subsidy vote. Key budget and appropriations issues remain ahead.

President Trump's plan to extend expiring Obamacare subsidies encounters GOP opposition and sparks bipartisan talks to prevent premium hikes and reform healthcare funding.

Medicare 2026 premiums surge nearly 10%, with fewer Medicare Advantage plans as insurers scale back. Explore key Medicare cost drivers and market impacts.

The U.S. government passed H.R. 5371, ending the shutdown and extending Medicare telehealth flexibilities through January 2026, ensuring continued coverage and retroactive payments for telehealth claims.

CMS introduces the Ambulatory Specialty Model, a new mandatory payment model for specialists treating low back pain and heart failure, effective from 2027 to improve care quality and reduce costs.

Examining Aetna's new inpatient payment policy for Medicare Advantage plans, its conflicts with Medicare's Two-Midnight Rule, and implications for hospital reimbursement and compliance.

Novo Nordisk and Eli Lilly agree to lower GLP-1 drug prices in exchange for expanded Medicare and Medicaid coverage, marking a major shift in U.S. drug pricing and access.